An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-s...

por Gu, Linping, Yao, Yaxian, Chen, Zhiwei
Publicado 2021

Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases

por Sun, Yingjia, Ai, Xinghao, Shen, Shengping, Gu, Linping, Lu, Shun
Publicado 2015

Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report

por Gu, Linping, Ji, Wenxiang, Xu, Yunhua, Han, Yuchen, Jian, Hong
Publicado 2022

Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer

por Shen, Jie, Gu, Linping, Qi, Yuwen, Yao, Yaxian, Lu, Shun, Chen, Zhiwei
Publicado 2023

SMO mutation predicts the effect of immune checkpoint inhibitor: From NSCLC to multiple cancers

por Ji, Wenxiang, Niu, Xiaomin, Yu, Yongfeng, Li, Ziming, Gu, LinPing, Lu, Shun
Publicado 2022

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer

por Qi, Yuwen, Gu, Linping, Shen, Jie, Yao, Yaxian, Zhao, Yi, Lu, Shun, Chen, Zhiwei
Publicado 2023

Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to...

por Xu, Yunhua, Fang, Wangsheng, Cheng, Bingye, Chen, Shanshan, Gu, Linping, Zhu, Li, Pan, Yan, Zhou, Zhen
Publicado 2020

Landscape and Predictive Significance of the Structural Classification of EGFR Mutations in Chinese NSCLCs: A Real-World Study

por Gu, Linping, Huang, Huayan, Xu, Zhangwendi, Niu, Xiaomin, Li, Ziming, Xia, Liliang, Yu, Yongfeng, Lu, Shun
Publicado 2022

Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models

por Xu, Yunhua, Gu, Linping, Li, Yingqi, Zhao, Ruiying, Jian, Hong, Xie, Wenhui, Liu, Liu, Wu, Huiwen, Ren, Fang, Han, Yuchen, Lu, Shun
Publicado 2022

An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis

por Gu, Linping, Wang, Xue, Sun, Yile, Xu, Yunhua, Niu, Xiaomin, Zhao, Ruiying, Yao, Yaxian, Jian, Hong, Han, Yuchen, Wei, Jinwang, Chen, Zhiwei, Lu, Shun
Publicado 2022

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

por Zhou, Zhen, Ding, Zhengping, Yuan, Jie, Shen, Shengping, Jian, Hong, Tan, Qiang, Yang, Yunhai, Chen, Zhiwei, Luo, Qingquan, Cheng, Xinghua, Yu, Yongfeng, Niu, Xiaomin, Qian, Liqiang, Chen, Xiaoke, Gu, Linping, Liu, Ruijun, Ma, Shenglin, Huang, Jia, Chen, Tianxiang, Li, Ziming, Ji, Wenxiang, Song, Liwei, Shen, Lan, Jiang, Long, Yu, Zicheng, Zhang, Chao, Tai, Zaixian, Wang, Changxi, Chen, Rongrong, Carbone, David P., Xia, Xuefeng, Lu, Shun
Publicado 2022